Pricing

Arca Biopharma Inc (ABIO)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO:
Michael R. Bristow
Employees:
6
10170 CHURCH RANCH WAY, SUITE 100, WESTMINSTER, CO, 80021
7209402200
    Formally known as:
  • Hyseq Inc.
  • Nuvelo Inc.
Stock Split History
DateRatio
2004-02-23 1:3
2013-03-05 1:6
2015-09-04 1:7
2019-04-04 1:18
ARCA biopharma, Inc. develops and commercializes genetically targeted therapies for cardiovascular diseases. The company was incorporated in 2004 and is headquartered in Westminster, Colorado. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 and Gencaro.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available